» Articles » PMID: 24534188

Neuronal Activity Regulates Extracellular Tau in Vivo

Overview
Journal J Exp Med
Date 2014 Feb 19
PMID 24534188
Citations 296
Authors
Affiliations
Soon will be listed here.
Abstract

Tau is primarily a cytoplasmic protein that stabilizes microtubules. However, it is also found in the extracellular space of the brain at appreciable concentrations. Although its presence there may be relevant to the intercellular spread of tau pathology, the cellular mechanisms regulating tau release into the extracellular space are not well understood. To test this in the context of neuronal networks in vivo, we used in vivo microdialysis. Increasing neuronal activity rapidly increased the steady-state levels of extracellular tau in vivo. Importantly, presynaptic glutamate release is sufficient to drive tau release. Although tau release occurred within hours in response to neuronal activity, the elimination rate of tau from the extracellular compartment and the brain is slow (half-life of ∼11 d). The in vivo results provide one mechanism underlying neuronal tau release and may link trans-synaptic spread of tau pathology with synaptic activity itself.

Citing Articles

Contributions of connectional pathways to shaping Alzheimer's disease pathologies.

Bougacha S, Roquet D, Landeau B, Saul E, Naveau M, Sherif S Brain Commun. 2025; 7(1):fcae459.

PMID: 39763634 PMC: 11702304. DOI: 10.1093/braincomms/fcae459.


Distinct regulation of Tau Monomer and aggregate uptake and intracellular accumulation in human neurons.

Marvian A, Strauss T, Tang Q, Tuck B, Keeling S, Rudiger D Mol Neurodegener. 2024; 19(1):100.

PMID: 39736627 PMC: 11686972. DOI: 10.1186/s13024-024-00786-w.


Neuroinflammation in Alzheimer disease.

Heneka M, van der Flier W, Jessen F, Hoozemanns J, Thal D, Boche D Nat Rev Immunol. 2024; .

PMID: 39653749 DOI: 10.1038/s41577-024-01104-7.


Cerebral hyperactivation across the Alzheimer's disease pathological cascade.

Corriveau-Lecavalier N, Adams J, Fischer L, Molloy E, Maass A Brain Commun. 2024; 6(6):fcae376.

PMID: 39513091 PMC: 11542485. DOI: 10.1093/braincomms/fcae376.


Arc mediates intercellular tau transmission via extracellular vesicles.

Tyagi M, Chadha R, de Hoog E, Sullivan K, Walker A, Northrop A bioRxiv. 2024; .

PMID: 39484489 PMC: 11526995. DOI: 10.1101/2024.10.22.619703.


References
1.
Bancher C, Braak H, Fischer P, Jellinger K . Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett. 1993; 162(1-2):179-82. DOI: 10.1016/0304-3940(93)90590-h. View

2.
Frost B, Jacks R, Diamond M . Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009; 284(19):12845-52. PMC: 2676015. DOI: 10.1074/jbc.M808759200. View

3.
Luk K, Kehm V, Carroll J, Zhang B, OBrien P, Trojanowski J . Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012; 338(6109):949-53. PMC: 3552321. DOI: 10.1126/science.1227157. View

4.
Liu L, Drouet V, Wu J, Witter M, Small S, Clelland C . Trans-synaptic spread of tau pathology in vivo. PLoS One. 2012; 7(2):e31302. PMC: 3270029. DOI: 10.1371/journal.pone.0031302. View

5.
Eckermann K, Mocanu M, Khlistunova I, Biernat J, Nissen A, Hofmann A . The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J Biol Chem. 2007; 282(43):31755-65. DOI: 10.1074/jbc.M705282200. View